Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Emergency Medicine
Volume 2014 (2014), Article ID 848030, 3 pages
http://dx.doi.org/10.1155/2014/848030
Case Report

Emergency Open Incarcerated Hernia Repair with a Biological Mesh in a Patient with Colorectal Liver Metastasis Receiving Chemotherapy and Bevacizumab Uncomplicated Wound Healing

1Department of Surgery, The London Clinic, 20 Devonshire Pl, London W1G 6BW, UK
2Upper GI/HPB Unit, Department of Academic Surgery, Royal Marsden Hospital, Fulham Roadd, London SW3 6JJ, UK
3Division of Transplantation, Department of Surgery, Hippokration General Hospital, Aristotle University of Thessaloniki, 49 Kostantinoupoleos Street, 54642 Thessaloniki, Greece

Received 13 October 2014; Accepted 4 December 2014; Published 21 December 2014

Academic Editor: Vasileios Papadopoulos

Copyright © 2014 Alexandros Giakoustidis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lomanto, S. G. Iyer, A. Shabbir, and W.-K. Cheah, “Laparoscopic versus open ventral hernia mesh repair: a prospective study,” Surgical Endoscopy and Other Interventional Techniques, vol. 20, no. 7, pp. 1030–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. W. Luijendijk, W. C. J. Hop, M. P. van den Tol et al., “A comparison of suture repair with mesh repair for incisional hernia,” The New England Journal of Medicine, vol. 343, no. 6, pp. 392–398, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. C. W. Iqbal, T. H. Pham, A. Joseph, J. Mai, G. B. Thompson, and M. G. Sarr, “Long-term outcome of 254 complex incisional hernia repairs using the modified rives-stoppa technique,” World Journal of Surgery, vol. 31, no. 12, pp. 2398–2404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Chaudhury, M. Hassanain, N. Bouganim, A. Salman, P. Kavan, and P. Metrakos, “Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis,” HPB, vol. 12, no. 1, pp. 37–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Kemeny, “Presurgical chemotherapy in patients being considered for liver resection,” The Oncologist, vol. 12, no. 7, pp. 825–839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. R. Howdieshell, D. Callaway, W. L. Webb et al., “Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation,” Journal of Surgical Research, vol. 96, no. 2, pp. 173–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Taniguchi, S. Sakisaka, K. Matsuo, K. Tanikawa, and M. Sata, “Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats,” Journal of Histochemistry and Cytochemistry, vol. 49, no. 1, pp. 121–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. L. B. Saltz, S. Clarke, E. Díaz-Rubio et al., “Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study,” Journal of Clinical Oncology, vol. 26, no. 12, pp. 2013–2019, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Hurwitz, L. Fehrenbacher, W. Novotny et al., “Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2335–2342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. F. A. Scappaticci, J. R. Skillings, S. N. Holden et al., “Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab,” Journal of the National Cancer Institute, vol. 99, no. 16, pp. 1232–1239, 2007. View at Google Scholar
  11. S. Wu, C. Kim, L. Baer, and X. Zhu, “Bevacizumab increases risk for severe proteinuria in cancer patients,” Journal of the American Society of Nephrology, vol. 21, no. 8, pp. 1381–1389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Elice and F. Rodeghiero, “Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact,” Thrombosis research, vol. 125, pp. S55–S57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Mahfud, S. Breitenstein, A. M. El-Badry et al., “Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study,” World Journal of Surgery, vol. 34, no. 1, pp. 92–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. I. Alaedeen, J. Lipman, D. Medalie, and M. J. Rosen, “The single-staged approach to the surgical management of abdominal wall hernias in contaminated fields,” Hernia, vol. 11, no. 1, pp. 41–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Davies, C. Davies, G. Morris-Stiff, and K. Shute, “Emergency presentation of abdominal hernias: Outcome and reasons for delay in treatment—a prospective study,” Annals of the Royal College of Surgeons of England, vol. 89, no. 1, pp. 47–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zafar, M. Zaidi, I. Qadir, and A. A. Memon, “Emergency incisional hernia repair: a difficult problem waiting for a solution,” Annals of Surgical Innovation and Research, vol. 6, article 1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Pascual, S. Sotomayor, M. Rodríguez, B. Pérez-Köhler, and J. M. Bellón, “Repair of abdominal wall defects with biodegradable laminar prostheses: polymeric or biological?” PLoS ONE, vol. 7, no. 12, Article ID e52628, 2012. View at Publisher · View at Google Scholar · View at Scopus